Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D Hall

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Journal of Clinical Pharmacology|February 5, 2015
Assessment of the persistence of anacetrapib and evacetrapib concentrations using two pharmacokinetic modeling approachesDavid S Small, Alice Ban Ke, Stephen D Hall, et al.
Scientific Reports|November 26, 2024
Characterising the inconsistency between perceived and actual sleep and its impact upon cognition and moodHannah Windmill, Alexander Dyer, Alastair D Smith, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 31, 2023
Impact of Heterotropic Allosteric Modulation on the Time-Dependent Inhibition of Cytochrome P450 3A4Luc R A Rougée, David W Bedwell, Kasi Hansen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 4, 2009
Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycinSara K Quinney, Xin Zhang, Aroonrut Lucksiri, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2008
Apparent high CYP3A5 expression is required for significant metabolism of vincristine by human cryopreserved hepatocytesJennifer B Dennison, Michael A Mohutsky, Robert J Barbuch, et al.
Frontiers in Human Neuroscience|April 19, 2013
A multimodal perspective on the composition of cortical oscillationsKim C Ronnqvist, Craig J McAllister, Gavin L Woodhall, et al.
Therapeutic Drug Monitoring|June 4, 2008
Quantification of vincristine and its major metabolite in human plasma by high-performance liquid chromatography/tandem mass spectrometryJennifer B Dennison, Jamie L Renbarger, David O Walterhouse, et al.
Frontiers in Neurology|January 11, 2020
Bradykinesia Is Driven by Cumulative Beta Power During Continuous Movement and Alleviated by Gabaergic Modulation in Parkinson's DiseaseEmma J Prokic, Ian M Stanford, Gavin L Woodhall, et al.
Clinical Pharmacology and Therapeutics|July 30, 2019
Quantitative Prediction of CYP3A4- and CYP3A5-Mediated Drug InteractionsYingying Guo, Aroonrut Lucksiri, Gemma L Dickinson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 12, 2005
Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearanceSilvana Borges, Lang Li, Mitchell A Hamman, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Journal of Clinical Pharmacology|February 5, 2015
Assessment of the persistence of anacetrapib and evacetrapib concentrations using two pharmacokinetic modeling approachesDavid S Small, Alice Ban Ke, Stephen D Hall, et al.
Scientific Reports|November 26, 2024
Characterising the inconsistency between perceived and actual sleep and its impact upon cognition and moodHannah Windmill, Alexander Dyer, Alastair D Smith, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 31, 2023
Impact of Heterotropic Allosteric Modulation on the Time-Dependent Inhibition of Cytochrome P450 3A4Luc R A Rougée, David W Bedwell, Kasi Hansen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 4, 2009
Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycinSara K Quinney, Xin Zhang, Aroonrut Lucksiri, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 25, 2008
Apparent high CYP3A5 expression is required for significant metabolism of vincristine by human cryopreserved hepatocytesJennifer B Dennison, Michael A Mohutsky, Robert J Barbuch, et al.
Frontiers in Human Neuroscience|April 19, 2013
A multimodal perspective on the composition of cortical oscillationsKim C Ronnqvist, Craig J McAllister, Gavin L Woodhall, et al.
Therapeutic Drug Monitoring|June 4, 2008
Quantification of vincristine and its major metabolite in human plasma by high-performance liquid chromatography/tandem mass spectrometryJennifer B Dennison, Jamie L Renbarger, David O Walterhouse, et al.
Frontiers in Neurology|January 11, 2020
Bradykinesia Is Driven by Cumulative Beta Power During Continuous Movement and Alleviated by Gabaergic Modulation in Parkinson's DiseaseEmma J Prokic, Ian M Stanford, Gavin L Woodhall, et al.
Clinical Pharmacology and Therapeutics|July 30, 2019
Quantitative Prediction of CYP3A4- and CYP3A5-Mediated Drug InteractionsYingying Guo, Aroonrut Lucksiri, Gemma L Dickinson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 12, 2005
Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearanceSilvana Borges, Lang Li, Mitchell A Hamman, et al.
Pageof 14